Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

NCT05482269 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT05482269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05482269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2011
Completion date
December 31, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, deterioration, clinical, pulmonary embolism and thrombosis